Bajaj Drug Impex Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 31 Year, 5 Months
- Satisfied Charges ₹ 0.42 M
About Bajaj Drug Impex
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1993PLC073781
- Company No.
073781
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Sep 1993
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Bajaj Drug Impex?
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sajankumar Bajaj ![]() | Director | 05-Apr-2002 | Current |
Financial Performance of Bajaj Drug Impex.
Enhance accessibility to Bajaj Drug Impex's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Bajaj Drug Impex?
Unlock access to Bajaj Drug Impex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)
₹0
₹0.42 M
Charges Breakdown by Lending Institutions
- The Saraswat Co-Op Bank Ltd : 0.04 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
13 Aug 1996 | The Saraswat Co-Op Bank Ltd | ₹0.07 M | Satisfied |
26 Apr 1995 | The Saraswat Co-Op Bank Ltd | ₹0.35 M | Satisfied |
How Many Employees Work at Bajaj Drug Impex?
Unlock and access historical data on people associated with Bajaj Drug Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Bajaj Drug Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bajaj Drug Impex's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.